Among the industry-sponsored clinical trials initiated in Q1 2017, oncology trials dominated the field, followed by clinical trials for CNS.

Figure 1: oncology dominates industry-sponsored clinical trials in Q1 2017

Source: GlobalData, Pharma Intelligence Center, Clinical Trials Database [Accessed April 30, 2017]

Among these studies, there are more Phase I (241) studies than Phase II (234) and Phase III (193), accounting for 29%, 28% and 23% of the total clinical trials, respectively.

Figure 2: industry-sponsored clinical trials initiated in Q1 2017 by phase 

Source: GlobalData, Pharma Intelligence Center, Clinical Trials Database [Accessed April 30, 2017]

Abbvie started the most clinical trials, followed by GSK in second place.

Figure 3: top sponsors for industry-sponsored clinical trials initiated in Q1 2017

Source: GlobalData, Pharma Intelligence Center, Clinical Trials Database [Accessed April 30, 2017]